What is USBC, Inc.'s earnings per share (EPS)?

USBC, Inc. (USBC) reported diluted earnings per share of -$0.39 for fiscal year 2025. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

USBC, Inc. (USBC) Financials

USBC

FY2025 annual

Net Income -$22.1M -33.4% YoY

EPS (Diluted) -$0.39 YoY not available

Free Cash Flow -$7.6M +41.1% YoY

Operating Cash Flow -$7.6M +40.8% YoY

Market Cap $172.7M as of Sep 16, 2026

Price / Sales n/m no revenue reported

Price / Earnings n/m net loss, so no earnings multiple, FY2025

Price / Book 3.7x on $46.4M equity, Q3 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Sep 16, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q3 FY2026, ended Jun 30, 2026 Reported Aug 7, 2026 Currency USD FYE September

Newest figures come from the 10-Q for Q3 FY2026, filed Aug 7, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the USBC SEC filings page.

This page shows USBC, Inc. (USBC) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI USBC FY2025 2026-08-29

Financing reshaped the balance sheet while the underlying operation continued consuming cash, with no latest-period revenue reported.

The reported capital structure reset between FY2024 and FY2025: total assets expanded from $3.7M to $125.1M, making leverage and liquidity more informative than margin analysis. Equity moved from -$2.2M to $97.1M, yet operating cash flow was still -$7.6M in FY2025; the financing change did not translate into operating self-funding.

FY2025 financing cash flow was $13.3M while operating cash flow was -$7.6M, so the balance-sheet improvement came from financing rather than the operating engine. The reported liquidity comparison equals 13.9 months of the latest annual operating outflow, but that measure does not indicate internally generated cash.

Free cash flow matched operating cash flow at -$7.6M because capital expenditures were $0; the cash shortfall came from operations, not reinvestment. Shares outstanding increased from 108.1M in FY2024 to 388.1M in FY2025, showing the balance-sheet reset coincided with a much larger share count.

Financial Health Signals

Financial health score not available

USBC, Inc. does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.

Piotroski F-Score Partial

3/6

USBC, Inc. passes 3 of 6 computable financial strength tests (3 of the nine could not be computed from available data). 2 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass.

Earnings Quality No Cash Backing

N/A

USBC, Inc. reported a net loss of $22.1M while operations used $7.6M of cash. With neither figure positive, the ratio between the two carries no quality signal.

Interest Coverage At Risk

N/A

USBC, Inc. reported an operating loss of $18.0M against $1.2M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.

Key Financial Metrics

Export CSV

Earnings & Revenue

EBITDA

-$16.4M

YoY-1217.4%

QoQ-40.9%

USBC, Inc.'s EBITDA was -$16.4M in Q3 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 1217.4% from the same quarter a year earlier. Against the prior quarter it is down 40.9%.

Net Income

-$20.8M

YoY-1260.0%

QoQ+18.7%

USBC, Inc. reported -$20.8M in net income in Q3 2026. This represents a decrease of 1260.0% from the same quarter a year earlier. Against the prior quarter it is up 18.7%.

EPS (Diluted)

-$0.05

QoQ+28.6%

USBC, Inc. earned -$0.05 per diluted share (EPS) in Q3 2026. Against the prior quarter it is up 28.6%.

Revenue

Not reported for Q3 2026.

Cash & Balance Sheet

Cash & Debt

$3.0M

YoY+1628.8%

QoQ+46.5%

5Y CAGR-26.5%

10Y CAGR+26.8%

USBC, Inc. held $3.0M in cash as of Q3 2026; long-term debt is not reported for that period.

Shares Outstanding

388M

QoQ0.0%

5Y CAGR+62.3%

10Y CAGR+73.6%

USBC, Inc. had 388M shares outstanding in Q3 2026. It is unchanged from the prior quarter.

Free Cash Flow

Not reported for Q3 2026.

Dividends Per Share

Not reported for Q3 2026.

Margins & Returns

Return on Equity

-44.8%

QoQ-2.1pp

USBC, Inc.'s ROE was -44.8% in Q3 2026, measuring profit generated per dollar of shareholder equity. Against the prior quarter it is down 2.1 percentage points.

Gross Margin

Not reported for Q3 2026.

Operating Margin

Not reported for Q3 2026.

Net Margin

Not reported for Q3 2026.

Capital Allocation

R&D Spending

$57K

YoY-76.0%

QoQ-73.7%

USBC, Inc. invested $57K in research and development in Q3 2026. This represents a decrease of 76.0% from the same quarter a year earlier. Against the prior quarter it is down 73.7%.

Share Buybacks

Not reported for Q3 2026.

Capital Expenditures

Not reported for Q3 2026.

USBC Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

USBC quarterly income statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Revenue	N/A	N/A	N/A	$0-100.0%	$4.4M	$0-100.0%	$122K-93.2%	$1.8M-58.1%	$4.3M-11.7%	$4.9M-19.1%	$6.0M-4.2%	$6.3M-21.2%	$8.0M-6.9%	$8.6M+8.2%	$7.9M-13.3%	$9.1M
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	$0-100.0%	$70K-94.9%	$1.4M-60.4%	$3.5M-12.2%	$4.0M	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	$0-100.0%	$52K-87.8%	$427K-48.1%	$822K-9.5%	$908K-8.1%	$988K-2.8%	$1.0M-21.1%	$1.3M-30.5%	$1.9M+17.5%	$1.6M+0.9%	$1.6M
R&D Expenses	N/A	$1.8M-71.3%	$6.1M-20.9%	$7.7M+43.5%	$5.4M+35.7%	$4.0M+95.2%	$2.0M+61.7%	$1.3M+120.5%	$571K+618.5%	$79K-75.6%	$326K-10.2%	$363K-45.9%	$671K-42.6%	$1.2M+560.8%	$177K+32.1%	$134K
SG&A Expenses	N/A	$16.3M+78.9%	$9.1M+38.6%	$6.6M-19.1%	$8.1M+25.4%	$6.5M+33.7%	$4.8M+15.8%	$4.2M+66.7%	$2.5M-18.8%	$3.1M-8.0%	$3.4M+12.5%	$3.0M-6.2%	$3.2M-30.6%	$4.6M+26.4%	$3.6M-1.8%	$3.7M
Operating Income	N/A	-$18.0M-18.5%	-$15.2M-8.6%	-$14.0M-11.5%	-$12.6M-20.4%	-$10.4M-53.0%	-$6.8M-36.2%	-$5.0M-122.0%	-$2.3M+30.4%	-$3.2M-20.4%	-$2.7M-15.6%	-$2.3M+9.0%	-$2.6M+34.2%	-$3.9M-75.3%	-$2.2M+1.7%	-$2.3M
EBITDA	N/A	-$18.0M-19.0%	-$15.1M-10.4%	-$13.7M-11.9%	-$12.3M-19.6%	-$10.2M-55.6%	-$6.6M-38.5%	-$4.8M-123.7%	-$2.1M+32.8%	-$3.2M-25.8%	-$2.5M-27.2%	-$2.0M+7.8%	-$2.1M+38.7%	-$3.5M-87.4%	-$1.9M+0.5%	-$1.9M
Interest Expense	N/A	$1.2M+42.7%	$831K+113.3%	$390K-95.2%	$8.0M-46.1%	$14.9M+144.7%	$6.1M+106.9%	$2.9M+146.4%	$1.2M+217.1%	$377K+16.4%	$324K+90.3%	$170K+62.4%	$105K-39.5%	$173K-62.6%	$464K+118.2%	$213K
Income Tax	N/A	-$173K	$0	$0	$0	$0	$0	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Income	N/A	-$22.1M-33.4%	-$16.6M-8.5%	-$15.3M+23.8%	-$20.1M+20.9%	-$25.4M-87.0%	-$13.6M-78.2%	-$7.6M-133.7%	-$3.3M+16.5%	-$3.9M-123.4%	-$1.7M-166.4%	$2.6M+158.6%	$1.0M+115.4%	-$6.6M-141.8%	-$2.7M-13.4%	-$2.4M
EPS (Diluted)	$2.34	-$0.39	-$7.85	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Diluted Shares (Avg)	N/A	63M	2M	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q3'2610-Q	Q2'2610-Q	Q1'2610-K	Q4'2510-K	Q3'2510-Q	Q2'2510-Q	Q1'2510-K	Q4'2410-K
R&D Expenses	$57K-76.0%	$218K-47.8%	$254K-68.4%	N/A	$239K-82.3%	$418K-80.8%	$802K-46.0%	N/A
SG&A Expenses	$16.4M+1511.9%	$11.4M+539.9%	$16.9M+758.7%	N/A	$1.0M-59.2%	$1.8M-29.9%	$2.0M-2.3%	N/A
Operating Income	-$16.4M-1209.9%	-$11.7M-428.5%	-$17.1M-518.9%	N/A	-$1.3M+67.3%	-$2.2M+53.3%	-$2.8M+20.9%	N/A
EBITDA	-$16.4M-1217.4%	-$11.7M-430.0%	-$17.1M-520.9%	N/A	-$1.2M+67.3%	-$2.2M	-$2.8M+20.7%	N/A
Interest Expense	$220K-20.3%	$14K-99.0%	N/A	N/A	$276K-7.6%	$1.4M+91.7%	$1.2M	N/A
Income Tax	-$5.2M	-$6.7M	-$15.7M	N/A	$0	$0	$0	N/A
Net Income	-$20.8M-1260.0%	-$25.6M-614.0%	-$27.5M-488.5%	N/A	-$1.5M+62.7%	-$3.6M+33.7%	-$4.7M-35.4%	N/A
EPS (Basic)	-$0.05+90.9%	-$0.07+94.4%	N/A	N/A	-$0.55	-$1.24	N/A	N/A
EPS (Diluted)	-$0.05	-$0.07	-$0.07	$2.53	-$0.55	-$1.24	-$0.040.0%	-$1.43
Diluted Shares (Avg)	388M	388M	388M	N/A	7M	3M	108M+33.8%	N/A

Not reported in any period shown, so not listed: Revenue, Cost of Revenue, Gross Profit.

USBC Balance Sheet

USBC quarterly balance sheet

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Total Assets	$125.1M+3313.3%	$3.7M-55.7%	$8.3M-39.9%	$13.8M+6.7%	$12.9M+175.3%	$4.7M+77.4%	$2.6M+25.5%	$2.1M+77.0%	$1.2M-54.8%	$2.6M+6.9%	$2.5M-23.6%	$3.2M-30.4%	$4.6M-13.0%	$5.3M+23.3%	$4.3M
Current Assets	$9.8M+213.7%	$3.1M-61.2%	$8.0M-36.3%	$12.6M+2.7%	$12.3M+185.2%	$4.3M+117.4%	$2.0M+33.7%	$1.5M+40.8%	$1.1M-20.0%	$1.3M+38.5%	$948K-30.0%	$1.4M-44.6%	$2.4M-11.3%	$2.8M+65.4%	$1.7M
Cash & Equivalents	$8.8M+183.6%	$3.1M-61.2%	$8.0M-36.3%	$12.6M+2.7%	$12.3M+185.2%	$4.3M+126.1%	$1.9M+103.4%	$934K+805.6%	$103K-45.2%	$188K+128.9%	$82K+16.9%	$70K-90.6%	$747K-34.5%	$1.1M+1136.2%	$92K
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Inventory	N/A	N/A	N/A	N/A	N/A	$0-100.0%	$7K-96.5%	$204K-9.9%	$226K-23.5%	$295K+35.5%	$218K-47.2%	$413K-31.3%	$601K+74.3%	$345K-24.2%	$455K
Accounts Receivable	$0	N/A	N/A	N/A	N/A	$0-100.0%	$63K-80.3%	$321K-53.8%	$693K-14.3%	$809K+30.5%	$620K-24.0%	$815K0.0%	$815K-19.5%	$1.0M+22.9%	$824K
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$0-100.0%	$984K0.0%	$984K0.0%	$984K0.0%	$984K0.0%	$984K0.0%	$984K
Total Liabilities	$28.0M+380.4%	$5.8M+28.7%	$4.5M+16.1%	$3.9M-66.6%	$11.6M+76.6%	$6.6M+11.1%	$5.9M+26.0%	$4.7M-8.5%	$5.1M-5.4%	$5.4M-30.6%	$7.8M+18.2%	$6.6M-10.8%	$7.4M+44.4%	$5.1M-13.1%	$5.9M
Current Liabilities	$3.7M-27.6%	$5.2M+14.2%	$4.5M+18.7%	$3.8M-65.5%	$11.0M+73.9%	$6.3M+9.2%	$5.8M+23.5%	$4.7M-8.5%	$5.1M-5.4%	$5.4M-30.6%	$7.8M+18.2%	$6.6M-10.2%	$7.4M+44.4%	$5.1M+5.1%	$4.9M
Non-Current Liabilities	$24.2M+3585.1%	$657K	$0-100.0%	$87K-85.7%	$610K+144.6%	$249K+105.1%	$122K	$0	$0	$0	$0	$0-100.0%	$51K+42.3%	$36K-96.6%	$1.1M
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A	$0	$0	$0	$0	$0	$0-100.0%	$2K-52.8%	$4K-99.6%	$1.0M
Total Equity	$97.1M+4604.2%	-$2.2M-157.6%	$3.7M-62.0%	$9.9M+694.0%	$1.2M+164.9%	-$1.9M+41.9%	-$3.3M-26.4%	-$2.6M+34.2%	-$4.0M-41.0%	-$2.8M+47.8%	-$5.4M-57.8%	-$3.4M-21.4%	-$2.8M-1745.2%	$171K+110.6%	-$1.6M
Retained Earnings	-$163.1M-17.6%	-$138.7M-13.9%	-$121.8M-20.2%	-$101.4M-24.7%	-$81.3M-45.3%	-$56.0M-32.0%	-$42.4M-21.9%	-$34.8M-10.3%	-$31.5M-16.5%	-$27.1M-12.0%	-$24.2M-12.2%	-$21.5M-4.9%	-$20.5M-47.6%	-$13.9M-24.4%	-$11.2M

Metric	Q3'2610-Q	Q2'2610-Q	Q1'2610-K	Q4'2510-K	Q3'2510-Q	Q2'2510-Q	Q1'2510-K	Q4'2410-K
Total Assets	$66.5M+13398.1%	$72.3M+7720.8%	$93.7M+5953.3%	$125.1M+3313.3%	$493K-82.0%	$924K-81.3%	$1.5M-69.1%	$3.7M-55.7%
Current Assets	$4.6M+2545.1%	$3.4M+671.4%	$6.8M+558.1%	$9.8M+213.7%	$173K-91.9%	$444K-90.6%	$1.0M-78.6%	$3.1M-61.2%
Cash & Equivalents	$3.0M+1628.8%	$2.0M+358.4%	$4.1M+296.4%	$8.8M+183.6%	$173K-91.9%	$444K-90.6%	$1.0M-78.6%	$3.1M-61.2%
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Accounts Receivable	N/A	N/A	$2.3M	$0	N/A	N/A	N/A	N/A
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Total Liabilities	$20.1M+280.1%	$12.4M+81.8%	$12.1M+122.2%	$28.0M+380.4%	$5.3M-28.0%	$6.8M+1.7%	$5.5M+44.2%	$5.8M+28.7%
Current Liabilities	$20.0M+289.4%	$10.7M+61.0%	$3.7M-29.3%	$3.7M-27.6%	$5.1M-16.1%	$6.6M+31.0%	$5.2M+37.3%	$5.2M+14.2%
Non-Current Liabilities	$104K-32.0%	$1.7M+874.9%	$8.5M+3116.8%	$24.2M+3585.1%	$153K-87.5%	$174K-89.3%	$263K	$657K
Total Equity	$46.4M+1068.3%	$59.9M+1118.1%	$81.5M+2182.6%	$97.1M+4604.2%	-$4.8M-4.1%	-$5.9M-235.4%	-$3.9M-419.4%	-$2.2M-157.6%
Retained Earnings	-$236.9M-57.2%	-$216.1M-47.0%	-$190.5M-32.8%	-$163.1M-17.6%	-$150.7M-11.6%	-$147.0M-12.4%	-$143.4M-14.4%	-$138.7M-13.9%

Not reported in any period shown, so not listed: Inventory, Goodwill, Long-Term Debt.

USBC Cash Flow Statement

USBC quarterly cash flow statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Operating Cash Flow	-$23.0M	-$7.6M+40.8%	-$12.8M-23.9%	-$10.4M-49.6%	-$6.9M-1.0%	-$6.9M-75.0%	-$3.9M-26.1%	-$3.1M-177.9%	-$1.1M+11.6%	-$1.3M+54.0%	-$2.7M-1044.9%	-$240K+82.6%	-$1.4M+60.6%	-$3.5M-5922.6%	-$58K+95.6%	-$1.3M
Depreciation & Amortization	N/A	$31K-61.2%	$81K-74.2%	$313K-2.5%	$321K+59.9%	$201K-17.4%	$243K-6.3%	$259K+95.6%	$133K+63.2%	$81K-54.5%	$179K-49.4%	$353K-15.6%	$418K+5.1%	$398K+11.7%	$356K-7.4%	$385K
Stock-Based Compensation	N/A	$7.4M+150.4%	$3.0M+0.1%	$3.0M	N/A	$1.0M-39.6%	$1.7M+49.1%	$1.1M+2143.0%	$51K+34.5%	$38K-18.4%	$46K-29.1%	$65K-25.2%	$88K-65.0%	$250K-6.1%	$266K+76.1%	$151K
Capital Expenditures	N/A	$0-100.0%	$66K-17.9%	$81K-90.6%	$855K+185.6%	$300K+327.1%	$70K-12.3%	$80K-17.8%	$97K+3884.1%	-$2K-89.6%	$23K	$0	$0-100.0%	$26K-76.3%	$109K-9.8%	$121K
Free Cash Flow	N/A	-$7.6M+41.1%	-$12.9M-23.6%	-$10.4M-34.2%	-$7.8M-8.7%	-$7.2M-79.5%	-$4.0M-25.1%	-$3.2M-162.2%	-$1.2M+4.1%	-$1.3M+54.3%	-$2.8M-1054.7%	-$240K+82.6%	-$1.4M+60.9%	-$3.5M-2009.1%	-$167K+88.3%	-$1.4M
Investing Cash Flow	-$225K	$0+100.0%	-$66K+17.9%	-$81K+90.6%	-$855K-185.6%	-$300K-327.1%	-$70K+12.3%	-$80K+17.8%	-$97K-387.1%	$34K+301.0%	-$17K-178.6%	$21K-26.8%	$29K+345.5%	-$12K+88.1%	-$100K+7.0%	-$108K
Financing Cash Flow	$26.7M	$13.3M+66.7%	$8.0M+36.1%	$5.9M-27.7%	$8.1M-46.3%	$15.1M+136.8%	$6.4M+53.8%	$4.2M+102.9%	$2.0M+78.6%	$1.1M-60.1%	$2.9M+1145.8%	$230K-65.8%	$673K-78.4%	$3.1M+158.6%	$1.2M-15.5%	$1.4M
Share Buybacks	N/A	N/A	N/A	$0-100.0%	$855K	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q3'2610-Q	Q2'2610-Q	Q1'2610-K	Q4'2510-K	Q3'2510-Q	Q2'2510-Q	Q1'2510-K	Q4'2410-K
Operating Cash Flow	-$8.2M-532.5%	-$7.1M-443.3%	-$4.6M-143.9%	-$3.1M+4.6%	-$1.3M+48.9%	-$1.3M+64.5%	-$1.9M+44.0%	-$3.3M-136.3%
Depreciation & Amortization	$0-100.0%	$6K-13.7%	$7K-30.4%	$7K-67.3%	$7K-65.3%	$7K	$10K-47.2%	$22K
Stock-Based Compensation	$7.3M+4040.3%	$3.9M+561.2%	$11.9M+2055.1%	N/A	$176K	$594K	$551K-21.2%	N/A
Capital Expenditures	N/A	N/A	$0	$0	$0-100.0%	$0-100.0%	$0-100.0%	$0-100.0%
Free Cash Flow	N/A	N/A	-$4.6M-143.9%	-$3.1M+4.6%	-$1.3M+49.9%	-$1.3M+64.5%	-$1.9M+44.3%	-$3.3M-136.3%
Investing Cash Flow	-$225K	$0	$0	$0	$0+100.0%	$0-100.0%	$0+100.0%	$0-100.0%
Financing Cash Flow	$10.0M+880.5%	$5.0M+603.6%	-$99K+44.7%	$11.8M+177.5%	$1.0M	$711K-79.9%	-$180K-188.6%	$4.2M-22.6%

Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.

USBC Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

USBC quarterly financial ratios

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Gross Margin	N/A	N/A	N/A	N/A	N/A	42.8%+19.2pp	23.6%+4.5pp	19.1%+0.5pp	18.6%+2.2pp	16.4%+0.2pp	16.2%0.0pp	16.2%-5.5pp	21.6%+1.7pp	19.9%+2.8pp	17.1%
Operating Margin	N/A	N/A	N/A	-288.4%	N/A	-5597.8%	-277.7%	-52.5%+14.1pp	-66.5%-21.8pp	-44.7%-7.7pp	-37.0%-5.0pp	-32.1%+13.4pp	-45.4%-17.4pp	-28.0%-3.3pp	-24.7%
Net Margin	N/A	N/A	N/A	-460.3%	N/A	-11122.5%	-421.7%	-75.7%+4.3pp	-80.0%-51.0pp	-29.0%-70.8pp	41.8%+29.1pp	12.7%+89.8pp	-77.0%-42.6pp	-34.5%-8.1pp	-26.4%
Return on Equity	-22.8%	N/A	-408.4%-204.9pp	-203.5%+1838.1pp	-2041.6%	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	-1601.2%	N/A
Return on Assets	-17.7%+434.8pp	-452.5%-267.5pp	-185.0%-39.1pp	-145.9%+50.9pp	-196.8%+92.9pp	-289.7%-1.3pp	-288.4%-133.5pp	-154.9%+173.4pp	-328.3%-261.9pp	-66.4%-173.3pp	106.9%+75.3pp	31.6%+174.3pp	-142.7%-91.3pp	-51.3%+4.5pp	-55.9%
Current Ratio	2.61+2.0x	0.60-1.2x	1.77-1.5x	3.31+2.2x	1.11+0.4x	0.68+0.3x	0.340.0x	0.31+0.1x	0.200.0x	0.24+0.1x	0.12-0.1x	0.20-0.1x	0.33-0.2x	0.54+0.2x	0.34
Debt-to-Equity	0.29	N/A	1.21+0.8x	0.40-9.0x	9.38	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	0.02	N/A
Asset Turnover	N/A	N/A	0.00-0.3x	0.32+0.3x	0.000.0x	0.03-0.7x	0.68-1.4x	2.05-2.1x	4.10+1.8x	2.29-0.3x	2.56+0.1x	2.48+0.6x	1.85+0.4x	1.49-0.6x	2.12
FCF Margin	N/A	N/A	N/A	-178.3%	N/A	-3267.2%	-176.4%	-28.2%-2.2pp	-26.0%+20.0pp	-46.0%-42.2pp	-3.8%+13.5pp	-17.3%+23.9pp	-41.2%-39.1pp	-2.1%+13.6pp	-15.7%

Metric	Q3'2610-Q	Q2'2610-Q	Q1'2610-K	Q4'2510-K	Q3'2510-Q	Q2'2510-Q	Q1'2510-K	Q4'2410-K
Return on Equity	-44.8%	-42.7%	-33.7%	N/A	N/A	N/A	N/A	N/A
Return on Assets	-31.3%+279.1pp	-35.4%+351.9pp	-29.3%+272.2pp	N/A	-310.3%-160.7pp	-387.3%-277.9pp	-301.5%-232.8pp	N/A
Current Ratio	0.23+0.2x	0.32+0.3x	1.85+1.6x	2.61+2.0x	0.03-0.3x	0.07-0.9x	0.20-1.1x	0.60-1.2x
Debt-to-Equity	0.43	0.21	0.15	0.29	N/A	N/A	N/A	N/A

Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Net Margin, Asset Turnover, FCF Margin.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company	Fiscal year	Revenue	Net income	Net margin	Market cap	Health score
USBC, Inc. USBC	FY2025	N/A	-$22.1M	N/A	$172.7M	—
Mesa Laboratories Inc MLAB	FY2026	$249.1M	$6.7M	2.7%	$711.5M	45/100
Microvision Inc MVIS	FY2025	$1.2M	-$95.0M	N/A	$46.8M	43/100
Vishay Precision Group, Inc. VPG	FY2025	$307.2M	$5.3M	1.7%	$807.0M	58/100
Ituran Location and Control Ltd. ITRN	FY2025	$359.0M	$58.0M	16.2%	$1.0B	74/100

Where USBC, Inc. Ranks

Frequently Asked Questions

Is USBC, Inc. profitable?

No, USBC, Inc. (USBC) reported a net income of -$22.1M in fiscal year 2025.

What is USBC, Inc.'s EBITDA?

USBC, Inc. (USBC) had EBITDA of -$18.0M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

What is USBC, Inc.'s return on equity (ROE)?

USBC, Inc. (USBC) has a return on equity of -22.8% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is USBC, Inc.'s free cash flow?

USBC, Inc. (USBC) recorded an outflow of $7.6M in free cash flow during fiscal year 2025. This represents a 41.1% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is USBC, Inc.'s operating cash flow?

USBC, Inc. (USBC) recorded an outflow of $7.6M in operating cash flow during fiscal year 2025, representing cash used by core business activities.

What are USBC, Inc.'s total assets?

USBC, Inc. (USBC) had $125.1M in total assets as of fiscal year 2025, including both current and long-term assets.

What are USBC, Inc.'s capital expenditures?

USBC, Inc. (USBC) reported no capital expenditure during fiscal year 2025.

How much does USBC, Inc. spend on research and development?

USBC, Inc. (USBC) invested $1.8M in research and development during fiscal year 2025.

How many shares does USBC, Inc. have outstanding?

USBC, Inc. (USBC) had 388M shares outstanding as of fiscal year 2025.

What is USBC, Inc.'s current ratio?

USBC, Inc. (USBC) had a current ratio of 2.61 as of fiscal year 2025, which is generally considered healthy.

What is USBC, Inc.'s debt-to-equity ratio?

USBC, Inc. (USBC) had a debt-to-equity ratio of 0.29 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is USBC, Inc.'s return on assets (ROA)?

USBC, Inc. (USBC) had a return on assets of -17.7% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is USBC, Inc.'s P/E ratio?

USBC, Inc. (USBC) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (FY2025). The market capitalization is $172.7M as of Sep 16, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is USBC, Inc.'s price-to-sales ratio?

USBC, Inc. (USBC) has no price-to-sales ratio at the moment: no revenue reported. The market capitalization is $172.7M as of Sep 16, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

How does USBC, Inc.'s liquidity compare with its operating cash outflow?

At the end of fiscal year 2025, USBC, Inc. (USBC) held $8.8M in cash, cash equivalents and investments, and reported an operating cash outflow of $7.6M over that year. Dividing the one by the other, the reported balance equals about 14 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.

What is USBC, Inc.'s Piotroski F-Score?

USBC, Inc. (USBC) has a Piotroski F-Score of 3 out of 6 computable signals; 3 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are USBC, Inc.'s earnings high quality?

USBC, Inc. (USBC) reported a net loss of $22.1M while operations used $7.6M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can USBC, Inc. cover its interest payments?

USBC, Inc. (USBC) reported an operating loss of $18.0M against $1.2M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.